Skip to content

Peddling a Fantasy: How Drugmakers are Misleading State Lawmakers| Essential: Pharmacy Compounding Podcast APC

Pharmacy Podcast Network

35m
Transcript

Original podcast

Where to listen

About this episode

In this edition of Essential, we look at two major issues facing pharmacy compounding. First is a state-by-state effort by pharma companies to pass laws restricting compounding, and second is a cryptic statement from the FDA about possible limitations on compounding with GLP-1 ingredients. They’re both Very Big Deals for pharmacists across the country. LinksFDA statement on GLP-1 drugs: https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs… and APC’s response: https://a4pc.org/news/apc-responds-to-fdas-glp-1-statement Stay up to date on our state Compounding Defense Initiative: compounding.com Join APC today: https://a4pc.org/membership Find us on social:LinkedIn: https://www.linkedin.com/company/a4pcrx/Facebook: https://www.facebook.com/a4pcrx/Instagram: https://www.instagram.com/a4pcrx/

Transcript

0:00
35:07

4,964 words · 3 speakers

Page updated · transcript and summary are machine-generated